Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Different staff in a dermatology clinic understand mostly their own tasks, not the full clinic process.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.